ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 111 filers reported holding ROIVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 2.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,742,704 | +15.9% | 1,690,300 | 0.0% | 0.36% | +23.3% |
| Q2 2023 | $17,038,224 | +36.6% | 1,690,300 | 0.0% | 0.29% | +25.8% |
| Q1 2023 | $12,474,414 | -7.6% | 1,690,300 | 0.0% | 0.23% | -13.9% |
| Q4 2022 | $13,505,497 | +153.4% | 1,690,300 | 0.0% | 0.27% | +153.3% |
| Q3 2022 | $5,330,000 | -20.9% | 1,690,300 | 0.0% | 0.10% | -27.1% |
| Q2 2022 | $6,738,000 | -17.6% | 1,690,300 | 0.0% | 0.14% | +12.5% |
| Q1 2022 | $8,177,000 | +22.0% | 1,690,300 | +141.5% | 0.13% | +48.8% |
| Q4 2021 | $6,703,000 | – | 700,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $13,075,632 | 99.02% |
| Patient Square Capital LP | 12,639,920 | $147,634,266 | 81.13% |
| QVT Financial LP | 112,541,536 | $1,314,485,140 | 74.33% |
| Two Seas Capital LP | 7,915,232 | $92,449,910 | 18.59% |
| Octagon Capital Advisors LP | 4,367,000 | $51,006,560 | 7.84% |
| SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $853,009,871 | 7.02% |
| Decheng Capital Management III (Cayman), LLC | 1,459,700 | $17,049,296 | 5.69% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $56,445,259 | 5.10% |
| Rubric Capital Management LP | 10,500,000 | $122,640,000 | 4.60% |
| Artia Global Partners LP | 914,023 | $10,675,789 | 4.44% |